Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The clinical implications of ADAMTS13 function: the perspectives of haemostaseologists.

Rangarajan S, Kessler C, Aledort L.

Thromb Res. 2013 Oct;132(4):403-7. doi: 10.1016/j.thromres.2013.07.027. Epub 2013 Aug 13. Review.

PMID:
24050828
2.

Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis.

Sonneveld MA, de Maat MP, Leebeek FW.

Blood Rev. 2014 Jul;28(4):167-78. doi: 10.1016/j.blre.2014.04.003. Epub 2014 Apr 22. Review. Erratum in: Blood Rev. 2014 Nov;28(6):281-2.

PMID:
24825749
3.

ADAMTS13 and microvascular thrombosis.

Tsai HM.

Expert Rev Cardiovasc Ther. 2006 Nov;4(6):813-25. Review.

4.

High shear dependent von Willebrand factor self-assembly fostered by platelet interaction and controlled by ADAMTS13.

Kragh T, Napoleone M, Fallah MA, Gritsch H, Schneider MF, Reininger AJ.

Thromb Res. 2014 Jun;133(6):1079-87. doi: 10.1016/j.thromres.2014.03.024. Epub 2014 Mar 10.

PMID:
24681085
5.

Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner.

Bao J, Xiao J, Mao Y, Zheng XL.

Arterioscler Thromb Vasc Biol. 2014 Feb;34(2):397-407. doi: 10.1161/ATVBAHA.113.302547. Epub 2013 Dec 19.

6.

[ADAMTS13, von Willebrand factor specific cleaving protease].

Veyradier A, Coppo P.

Med Sci (Paris). 2011 Dec;27(12):1097-105. doi: 10.1051/medsci/20112712016. Epub 2011 Dec 23. Review. French.

7.

Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.

Tersteeg C, de Maat S, De Meyer SF, Smeets MW, Barendrecht AD, Roest M, Pasterkamp G, Fijnheer R, Vanhoorelbeke K, de Groot PG, Maas C.

Circulation. 2014 Mar 25;129(12):1320-31. doi: 10.1161/CIRCULATIONAHA.113.006727. Epub 2014 Jan 21.

8.
9.

A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B.

Hulstein JJ, de Groot PG, Silence K, Veyradier A, Fijnheer R, Lenting PJ.

Blood. 2005 Nov 1;106(9):3035-42. Epub 2005 Jul 12.

10.

ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men.

Chion CK, Doggen CJ, Crawley JT, Lane DA, Rosendaal FR.

Blood. 2007 Mar 1;109(5):1998-2000. Epub 2006 Oct 19.

11.

[New marker in thrombotic thrombocytopenic purpura].

Gøtze JP, Hillarp A, Lindblom A, Björk P, Strandberg K, Nielsen LB.

Ugeskr Laeger. 2008 Aug 11;170(33):2446-9. Review. Danish.

PMID:
18761827
12.

Pathophysiology of thrombotic thrombocytopenic purpura.

Tsai HM.

Int J Hematol. 2010 Jan;91(1):1-19. doi: 10.1007/s12185-009-0476-1. Review.

13.

[Genetic polymorphism of von Willebrand factor (VWF)-cleaving protease, ADAMTS13].

Kokame K.

Brain Nerve. 2008 Nov;60(11):1325-32. Review. Japanese.

PMID:
19069166
14.

Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction.

Kaikita K, Soejima K, Matsukawa M, Nakagaki T, Ogawa H.

J Thromb Haemost. 2006 Nov;4(11):2490-3. Epub 2006 Aug 8. No abstract available.

15.

von Willebrand disease biology.

Blombäck M, Eikenboom J, Lane D, Denis C, Lillicrap D.

Haemophilia. 2012 Jul;18 Suppl 4:141-7. doi: 10.1111/j.1365-2516.2012.02840.x. No abstract available.

PMID:
22726098
16.

Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood.

Donadelli R, Orje JN, Capoferri C, Remuzzi G, Ruggeri ZM.

Blood. 2006 Mar 1;107(5):1943-50. Epub 2005 Nov 17.

17.

Current concepts in thrombotic thrombocytopenic purpura.

Tsai HM.

Annu Rev Med. 2006;57:419-36. Review.

18.

The role of ADAMTS13 in the new pathogenesis of TTP.

Peyvandi F.

Hematology. 2005;10 Suppl 1:47-8. Review. No abstract available.

PMID:
16188633
19.

ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.

Zheng XL.

Annu Rev Med. 2015;66:211-25. doi: 10.1146/annurev-med-061813-013241. Review.

20.

Methodologies and clinical utility of ADAMTS-13 activity testing.

Just S.

Semin Thromb Hemost. 2010 Feb;36(1):82-90. doi: 10.1055/s-0030-1248727. Epub 2010 Apr 13. Review.

PMID:
20391299

Supplemental Content

Support Center